SANTA CLARA, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be ...

SANTA CLARA, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial ...

SANTA CLARA, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company focused on sacropelvic surgical solutions, today confirmed that ...

SANTA CLARA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating ...

1,530 active U.S. physicians, representing growth of 27% $2.1 million in trailing 12-month average revenue per territory, representing an increase of 16% New Technology Add-on Payment (“NTAP”) of over ...

SI Bone is projected to record more than $200 million in worldwide revenue during fiscal year 2025, according to preliminary ...

Maheshwari announced, "We're updating our full year revenue guidance to range between $198 million to $200 million. This implies year-over-year growth of approximately 18% to 20% as compared to the ...

CEO Laura A. Francis highlighted that "We had a record number of U.S. physicians perform our procedures this quarter, reinforcing the expanding reach and clinical acceptance of our differentiated ...